Tomotaka Suzuki

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Magnetic Resonance Imaging

Candida Albicans

Acute Lymphoblastic Leukemia

Top Venues

Cancer medicine

Japanese journal of clinical oncology

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kentaro Hirade, Shigeru Kusumoto, Masahide Oki, Kazuhide Shiraga, Shinya Hagiwara, Kana Oiwa, Tomotaka Suzuki, Shiori Kinoshita, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation. Cancer medicine 13 (3) (2024)
Kentaro Hirade, Shigeru Kusumoto, Masahide Oki, Kazuhide Shiraga, Shinya Hagiwara, Kana Oiwa, Tomotaka Suzuki, Shiori Kinoshita, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation. Cancer medicine 13 (3) (2024)
Kentaro Hirade, Shigeru Kusumoto, Masahide Oki, Kazuhide Shiraga, Shinya Hagiwara, Kana Oiwa, Tomotaka Suzuki, Shiori Kinoshita, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation. Cancer medicine 13 (3) (2024)
Kentaro Hirade, Shigeru Kusumoto, Masahide Oki, Kazuhide Shiraga, Shinya Hagiwara, Kana Oiwa, Tomotaka Suzuki, Shiori Kinoshita, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation. Cancer medicine 13 (3) (2024)
Kentaro Hirade, Shigeru Kusumoto, Masahide Oki, Kazuhide Shiraga, Shinya Hagiwara, Kana Oiwa, Tomotaka Suzuki, Shiori Kinoshita, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation. Cancer medicine (2024)
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, Masahide Oki, Nozomi Nishitarumizu, Yoko Nakanishi, Yukiyasu Kato, Akimi Kawai, Naohiro Matsunaga, Toru Ebina, Tomoyuki Nakamura, Yoshiaki Marumo, Kana Oiwa, Shiori Kinoshita, Tomoko Narita, Asahi Ito, Atsushi Inagaki, Masaki Ri, Hirokazu Komatsu, Takashi Aritsu, Shinsuke Iida
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia. Cancer medicine (2023)
Tomotaka Suzuki, Dai Maruyama, Shinsuke Iida, Hirokazu Nagai
Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan. Japanese journal of clinical oncology 52 (9) (2022)
Tomotaka Suzuki, Dai Maruyama, Ryunosuke Machida, Tomoko Kataoka, Noriyasu Fukushima, Nobuyuki Takayama, Rie Ohba, Ken Omachi, Yoshitaka Imaizumi, Masahito Tokunaga, Hiroo Katsuya, Isao Yoshida, Kazutaka Sunami, Mitsutoshi Kurosawa, Nobuko Kubota, Hiroaki Morimoto, Miki Kobayashi, Kazuhito Yamamoto, Yoshihiro Kameoka, Yoshitoyo Kagami, Takayuki Tabayashi, Masaki Maruta, Tsutomu Kobayashi, Shinsuke Iida, Hirokazu Nagai
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105. Hematological oncology (2022)
Tomotaka Suzuki, Dai Maruyama, Akiko Miyagi-Maeshima, Junko Nomoto, Kinuko Tajima, Yuta Ito, Shunsuke Hatta, Sayako Yuda, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Hirokazu Taniguchi, Koji Izutsu, Yukio Kobayashi, Kensei Tobinai
Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy. Cancer medicine 10 (15) (2021)